Garden State Investment Advisory Services LLC Has $333,000 Stake in Danaher Co. (NYSE:DHR)

Garden State Investment Advisory Services LLC raised its holdings in Danaher Co. (NYSE:DHR) by 13.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,196 shares of the conglomerate’s stock after buying an additional 146 shares during the period. Garden State Investment Advisory Services LLC’s holdings in Danaher were worth $333,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Coronation Fund Managers Ltd. raised its position in Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after acquiring an additional 1,470 shares in the last quarter. Brookstone Capital Management lifted its stake in Danaher by 23.3% in the 2nd quarter. Brookstone Capital Management now owns 10,328 shares of the conglomerate’s stock valued at $2,595,000 after purchasing an additional 1,955 shares during the last quarter. Gradient Investments LLC grew its holdings in Danaher by 8.7% during the second quarter. Gradient Investments LLC now owns 934 shares of the conglomerate’s stock worth $233,000 after purchasing an additional 75 shares during the period. Oakworth Capital Inc. increased its position in Danaher by 30.1% during the second quarter. Oakworth Capital Inc. now owns 458 shares of the conglomerate’s stock worth $114,000 after buying an additional 106 shares during the last quarter. Finally, Boomfish Wealth Group LLC raised its stake in Danaher by 4.2% in the second quarter. Boomfish Wealth Group LLC now owns 3,443 shares of the conglomerate’s stock valued at $860,000 after buying an additional 140 shares during the period. 79.05% of the stock is owned by institutional investors.

Danaher Stock Up 0.2 %

Shares of NYSE DHR opened at $234.99 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 1 year low of $222.53 and a 1 year high of $281.70. The company has a 50 day simple moving average of $246.92 and a 200 day simple moving average of $257.43. The firm has a market cap of $169.73 billion, a PE ratio of 44.85, a price-to-earnings-growth ratio of 4.33 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same period last year, the company earned $2.02 EPS. Danaher’s revenue for the quarter was up 3.1% compared to the same quarter last year. On average, research analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio is presently 20.61%.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research analyst reports. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday. KeyCorp upped their price target on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. Evercore ISI upped their price target on shares of Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Finally, Stephens reiterated an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $287.95.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.